The MedTech Step-Up Webinar
Welcome to Lifeblood’s MedTech Step-Up Webinar where our aim is to make you venture backable.
At Lifeblood, we understand that transforming a groundbreaking medical innovation into a venture-backable company requires more than just a great idea—it demands the right strategic approach, team, and industry insight . Lifeblood
Our Step-Up Program is designed to bridge the gap between innovation and investment readiness. We provide early-stage MedTech companies with a comprehensive, founder-first roadmap, addressing critical legal, business and financial advisory, team building, and marketing strategies. Lifeblood
Through tactical, step-by-step guidance, we aim to equip you with the tools and insights necessary to attract serious capital and achieve long-term growth. Lifeblood
We’re excited to embark on this journey with you, turning your MedTech innovation into a thriving, industry-changing reality.
This is the MedTech Step-Up Program.
The MedTech Step-Up Webinar
#2 - Investment & Economic Outlook: Joseph Snyder & Cristiano Fontana
Hosts:
Joseph Snyder
Head of Talent and Co-Founder, Lifeblood
https://www.linkedin.com/in/josephasnyder1/
Cristiano Fontana
Head of Advisory, Lifeblood
https://www.linkedin.com/in/cristiano-fontana-medtech-businessdevelopment/
Guests:
David Uffer
Managing Director, Trinity Life Sciences
David brings over 30 years of executive level experience dedicated to MedTech to Trinity. He has experience across strategy consulting, transaction advisory, venture investing, as well as HEOR, market access and clinical affairs advisory all focused on device, diagnostics and digital health.
Before joining Trinity David led MedTech portfolio and investing at General Inception, a venture capital firm. Prior to that, Dave spent five years leading the MedTech practice as Senior Partner at Alira Health, a global advisory firm with practices across all healthcare consulting and execution.
In previous roles David led Business Development for a $5B division of Medtronic (legacy Covidien) in their respiratory, monitoring and med/surg products covering 22 business lines. He ran deals in M&A, distribution, co-development and also executed minority equity investments. Prior to Medtronic, David was Director of Corporate Development at Hologic running strategy and executing deals across gyn surgery, breast health, and molecular diagnostics.
https://www.linkedin.com/in/david-uffer-00a176/
Jonathan Norris
Managing Director, VC Relationship Managment, HSBC Innovation Banking
Jonathan Norris is a Managing Director at HSBC Innovation, with over two decades of experience in the healthcare and life sciences sector. A former litigation attorney, Jonathan has been immersed in healthcare investing since 1999, with a particular focus on equity and debt strategy across BioPharma, Medical Devices, Diagnostics/Tools, and Digital Health.
At HSBC Innovation, Jonathan advises both investors and executives by analyzing historical and current market trends, including venture investments, IPO activity, and M&A. He regularly supports C-level leadership with business planning, exit strategy, and access to capital, and is known for his insightful thought leadership on healthcare venture funding and deal flow.
Jonathan has authored numerous analyses on the flow of capital into the healthcare ecosystem and continues to be a trusted voice in the industry, helping shape strategic decision-making for both startups and investors.
https://www.linkedin.com/in/jonathan-norris-248556/
Diana Saraceni
Founder and Managing Partner, Panakes Partners
Diana Saraceni is a seasoned venture capitalist with over 20 years of experience in pan-European investments across Digital, Cleantech/Deep Tech, and Healthcare/Life Sciences. She is the Co-Founder and Managing Partner at Panakès Partners, where she plays a leading role in funding and scaling innovative startups.
Diana has successfully raised and managed multiple funds and has guided numerous portfolio companies to exits through trade sales and IPOs. Beyond investing, she actively contributes to the innovation ecosystem by serving on selection committees, chairing startup competitions, and advocating for greater gender balance in technology. She also lectures on Entrepreneurship and Venture Capital at leading academic institutions across Europe.